Depression Treatment

Depression ≠ sadness. Sadness has a thing it’s about. Depression doesn’t, it just follows you around like a Dementor sucking the light out of the world. The texts you didn’t answer, the meal you didn’t eat, the teeth you didn’t brush, all of it pulls the same weight… which is none.

The biology is real… serotonin, dopamine, and norepinephrine tank, and you can see it on a PET scan if you want to. That’s why you can KNOW you should get up and not be able to make your body do it. It’s like trying to run a diesel engine on regular gas… the chemicals are there, the engine’s there, none of it is combusting the way it should. Calling that lazy is like calling a flat tire bad driving.

Depression’s worst trick is that it lies to you about itself. It tells you nothing’s going to work, you’re not bad off enough to deserve treatment, treatment is for people who have it worse than you. Dudes especially fall for this one. They keep waiting until things get bad enough to justify reaching out, and either stay miserable for years, or end up taking a road they can’t turn back from. Those thoughts feel like facts when you’re inside them. They’re not, they’re symptoms, and you can act before your brain gives you permission to.

What gets called depression isn’t always depression

Before we get into the medications, a lot of what gets called depression and gets a prescription inside the first ten minutes of an appointment isn’t actually depression, it’s a life situation that’s been getting renamed for years. “Just stress” is what some guys have been calling depression for two years, “tough patch” is what others have been calling a marriage in real trouble, “I just drink to unwind” is what gets called the early version of a drinking problem getting away from you. The renaming doesn’t change what’s actually happening… it just makes the actual thing harder to address because nobody’s calling it by its real name.

This matters because the field treats depression like a chemistry-first diagnosis, and a lot of patients who get put on an SSRI for what’s actually an unaddressed life situation feel slightly less miserable but don’t really get better, because the chemistry isn’t the bottleneck for them. They needed somebody to name what was actually going wrong, which is the part of how I think about depression that sits underneath everything else. Most depression is real, some of what’s getting called depression is mislabeled life stuff, and the diagnostic step is where most providers cut corners because the chemistry-first appointment is faster, easier to bill, and lets everybody go home feeling like something happened.

What male-pattern depression actually looks like

The other thing that gets missed is depression in guys that doesn’t look like the version on the brochure. The brochure version is sad mood, crying, can’t get out of bed, withdrawn from the world. Male-pattern depression often shows up as irritability you can’t account for, drinking more than you want to, being short with everybody at home, wrecked sleep that you can’t quite explain, and a flat affect where stuff you used to like just doesn’t do it for you anymore, which you wrote off two years ago as getting older. A lot of guys who fit this picture have been seen by clinicians who didn’t recognize it because it didn’t look like the brochure, so the conversation became about “stress management” or “burnout” instead of treatment.

If you read the previous paragraph and your face moved, that’s depression in guys, and the bed thing is a movie cliche.

If you read the male-pattern paragraph and your face moved, that’s depression in guys, and the bed thing is a movie cliche.

What the field gets wrong on the first prescription

Most patients who land with a depression diagnosis tried one antidepressant once, decided antidepressants don’t work for them, and are now sitting in front of a new prescriber convinced this whole exercise is a waste of time. Usually what actually happened: Lexapro 10mg, nauseous and weirdly tired for two weeks, didn’t feel obviously different by week four, stopped picking up the refill. Three things went wrong, and none of them were the drug.

Those thoughts feel like facts when you’re inside them. They’re not, they’re symptoms, and you can act before your brain gives you permission to.

First, nobody told them clearly that side effects peak in weeks one and two while the antidepressant effect doesn’t usually show up until weeks four to six. The window where it feels like a bad trade is real, and it’s where most people quit. STAR*D, still the biggest real-world depression study we have, showed that only about a third of patients really respond to the first med they try, and most need two or three trials before something clicks. Going in knowing that changes the experience of the first one not working.

Second, the dose was probably too low or the timeline was too short. Six weeks at a real dose is the minimum trial, and quitting in week two because of side effects is quitting before the medication has done anything.

Third, and this is the place a lot of community psychiatry just gives up: partial response isn’t failure. Most patients on a reasonable SSRI dose at week six are partially better, not fully better, and the right next move is augmentation, not switching to a different SSRI. More on that in a minute.

The medication ladder, in the order I actually use it

First line is almost always an SSRI. Zoloft, Lexapro, Prozac, Celexa. Cheap, studied exhaustively, tolerable for most people. Starting doses are low (sertraline 25 to 50mg, escitalopram 5 to 10mg) and we titrate over a few weeks.

Second line for me is usually an SNRI. Effexor (venlafaxine) at 75 to 225mg and Cymbalta (duloxetine) at 30 to 60mg add a norepinephrine kick to the serotonin work, which helps if there’s heavy fatigue or co-occurring chronic pain. Venlafaxine has a brutal discontinuation syndrome if you skip doses, which is worth knowing before you start it rather than after.

Then come the atypicals. Wellbutrin (bupropion) is its own category, acts on dopamine and norepinephrine, doesn’t tank libido, doesn’t cause weight gain, often hands people some energy back. Trintellix (vortioxetine) is newer, gentler on sexual side effects, sometimes helps cognitive fog more than the older drugs. Remeron (mirtazapine) is sedating and increases appetite, which sounds like a problem until you meet the patient who hasn’t slept or eaten in three weeks.

TCAs (nortriptyline, amitriptyline) are older drugs. They work, sometimes better than the newer ones, but the side effect profile is heavier and the overdose risk is higher. We still reach for them when newer agents haven’t worked. MAOIs (Nardil, Parnate) are end of the line, effective but they come with a strict food list to follow (no aged cheeses, cured meats, fermented stuff, certain wines) because the wrong food on these drugs can spike your blood pressure to dangerous levels. Which means the patient has to be organized enough to follow that food list for years.

Augmentation, which is the move most providers skip

This is the place a lot of community psychiatry stops and shouldn’t. If you’ve been on a reasonable dose of an SSRI for six to eight weeks and you’re partially better but not really better, the next move usually isn’t switching to a different SSRI. It’s augmentation. Add a second agent that hits a different system instead of swapping the first one out.

The cleanest augmentation move is adding bupropion 150 to 300mg to an SSRI. Different neurochemical system, often reverses the sexual side effects of the SSRI, frequently moves the needle for people stuck at partial response. I reach for this constantly.

Lithium augmentation is old, underused, and quietly impressive. We’re talking 300 to 600mg added to an antidepressant, not bipolar doses, and the data goes back to the 80s. It’s cheap, it requires blood monitoring (lithium level, thyroid panel, kidney function every six months or so) which is why a lot of prescribers won’t touch it, but for the right patient it pulls people across the finish line.

Adding a small dose of an atypical antipsychotic (the newer antipsychotic class, used at much lower doses for depression than they’d be at for actual psychotic symptoms) is the newer answer for treatment-resistant cases. Abilify (aripiprazole) 2 to 5mg, Rexulti (brexpiprazole) 1 to 2mg, and Seroquel XR 150 to 300mg are FDA-approved as add-ons to antidepressants. They work. The trade-off is that they carry metabolic risk, weight gain, and the occasional movement side effect at higher doses, so we use the lowest dose that does the job and we check labs.

The boring part that does most of the actual work

Here’s the hot take: getting yourself to do things even when you don’t feel like doing them, plus fixing your sleep, do more of the actual work than the medication does for most people with mild to moderate depression. Medication makes the boring part possible, the boring part is what moves the depression.

If you’ve been depressed long enough that you’ve stopped believing treatment can help, that’s the depression talking, not the data.

The mechanism is annoying and unsexy. You schedule a walk for 9 AM Tuesday, you do it badly, you do it again Wednesday, and a few weeks of that has your mood following the behavior instead of the other way around. Patients hate this because it asks them to do the thing while they still feel like garbage, which is a fair complaint and also the answer. There’s thirty years of trial data on it, which is more than a lot of things in psychiatry can claim for themselves. It sits inside CBT (cognitive behavioral therapy, the structured worksheet-and-homework kind, not the talk-about-your-mother kind) as the piece that does most of the heavy lifting, but you don’t need a therapist to do it, you need a calendar and the willingness to keep your appointment with yourself.

Exercise. I know how that lands when you can’t get out of bed. Telling a depressed person to go for a run feels insulting, and I get it. The data is annoying though. Aerobic exercise, thirty minutes, three to five times a week, shows up in meta-analyses with effect sizes comparable to a mild antidepressant for mild-to-moderate depression. Doesn’t replace medication for severe cases. Works as an add-on for almost everybody.

Sleep is the one I push hardest. Depression breaks sleep and broken sleep deepens depression, and you’re stuck in the loop. Fixing sleep doesn’t fix depression by itself, but you can’t fix depression on top of unfixed sleep. Same bedtime every night, screens out of the bedroom, no alcohol in the four hours before bed, no scrolling at 2 AM. It’s boring and effective, and it’s the foundation everything else gets built on.

Where I land on medication, and where you land is up to you

I’ll lay out my personal view in a second, but the bigger thing first: if you want medication, you get medication. I’m a provider, not a parent. My job is to give you my honest take on what’s likely to work and what the trade-offs are, and your job is to decide what you actually want to do with that information. Sometimes that means I’m prescribing something I’d personally have voted against if it were my appointment, and that’s fine, the appointment isn’t mine. The most I’ll do is make it a disapproving yes, where you walk out with the prescription and a clear understanding of what I’d watch for and why I wasn’t thrilled about it. I hardly ever say no.

The field itself is wrong in both directions. Psychiatry overmedicates patients who could be doing the work without it and undermedicates patients whose chemistry has made the work impossible. Most clinicians pick one side of that error and stay there. Both sides are routine.

My personal view, as one data point you can take or leave: for a meaningful number of people who come in with depression, the work itself does the work. Naming what’s actually going wrong, fixing sleep, doing the do-things-anyway scheduled-walk version of behavior change badly for a few months, dealing honestly with the marital or job situation the depression is wrapped around. Around 60 percent of my patients end up not on antidepressants, not because I refused to prescribe but because we talked about it honestly and they decided they wanted to see what they could do without one first. That’s a perfectly reasonable answer when the patient isn’t in crisis, and it works often enough that I keep offering it as a real option.

For the patients who do go on medication, the meds earn their keep in two specific places. The first is when the chemistry is so off the floor that nothing else can land. You can’t make yourself do the walk-on-Tuesday work while your sleep has been wrecked for three months and your concentration is shot, you need an SSRI to get those back to baseline before any of the behavior change has somewhere to anchor. The second is for everybody else who CAN do the work, but for whom medication softens the blow while they’re doing it. The work is annoying, it sometimes hurts, shedding old relationships and patterns in favor of the grind of building new ones is the kind of thing nobody enjoys at full volume. An SSRI that takes the edge off lets you keep showing up for the work instead of being too wrecked to come back next week.

Treatment-resistant depression, and what to do when the obvious stuff fails

The technical definition: failure to respond to two adequate trials of antidepressants from different classes. About a third of people with depression end up here at some point. That’s not rare, that’s a third of the schedule any given week.

Ketamine changed the shape of this field. IV ketamine and the FDA-approved nasal spray (Spravato) can produce antidepressant effects within hours to days rather than weeks. It pulls a totally different lever than SSRIs and SNRIs do, what happens after is that your brain starts forming new neural connections quickly instead of the slow grow the older antidepressants depend on. Effects fade without repeat dosing, so it’s a series of infusions and then a maintenance protocol. Expensive, requires monitoring, and for the right patient it’s been the difference between functioning and not.

TMS (transcranial magnetic stimulation) is six weeks of daily outpatient sessions, around thirty minutes each, where a magnetic coil pulses over the left prefrontal cortex. No anesthesia, no cognitive side effects, no time off work. Response rates around 50 to 60 percent in treatment-resistant patients. Covered by most insurance now, which was not the case five years ago.

ECT has the worst PR of any treatment in psychiatry and is the single most effective treatment available for severe, treatment-resistant, or psychotic depression. 70 to 80 percent remission rates in those cases. The version run now is nothing like the movies. Brief general anesthesia, muscle relaxant so the body doesn’t convulse, a short controlled seizure under EEG monitoring. The main side effect is short-term memory loss around the treatment window that usually clears over a few weeks. The pattern with treatment-resistant patients who finally agree to try ECT is a course of eight to twelve sessions, twice a week, and somewhere in the middle of the course the person who’s been disabled for months starts answering work emails on his phone in the recovery room. The thing that should have been tried two years ago turned out to be what worked.

If you’ve been depressed long enough that you’ve stopped believing treatment can help, that’s the depression talking, not the data. The ladder underneath you is real, and most of the rungs are ones nobody ever told you exist.

Sources

1. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs. Lancet. 2018;391(10128):1357-1366. PMID 29477251.
2. Cuijpers P, Karyotaki E, Reijnders M, Ebert DD. Was Eysenck right after all? A reassessment of the effects of psychotherapy for adult depression. Epidemiol Psychiatr Sci. 2019;28(1):21-30. PMID 29486804.
3. Cuijpers P, Karyotaki E, Eckshtain D, et al. Psychotherapy for Depression Across Different Age Groups: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2020;77(7):694-702. PMID 32186668.
4. Gelenberg AJ, Freeman MP, Markowitz JC, et al. Practice guideline for the treatment of patients with major depressive disorder, third edition. American Psychiatric Association. 2010. APA practice guideline (PDF).
5. Uphoff E, Ekers D, Robertson L, et al. Behavioural activation therapy for depression in adults. Cochrane Database Syst Rev. 2020;(7):CD013305. PMID 32628293.